Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

174
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-biased Genetic Risk Loci and Causal Brain Proteins in Parkinson's Disease.

medRxiv : the preprint server for health sciences·2026
Same author

The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder.

Neurology·2026
Same author

Cerebellar Ataxia and Chorea: Genetic Etiologies and Key Considerations for Diagnosis and Management.

Movement disorders clinical practice·2026
Same author

Emerging insight in genetics and therapies in young-onset Parkinson's disease (YOPD): a comprehensive review.

Journal of neurology·2026
Same author

Automated Imaging Differentiation for Dementia: Including Alzheimer Disease Dementia and Dementia with Lewy Bodies.

Neurology open access·2026
Same author

Long-Term Outcomes of Subthalamic Nucleus and Globus Pallidus Interna Deep Brain Stimulation for Young-Onset Parkinson Disease.

Neurology. Clinical practice·2026

Related Experiment Video

Updated: May 22, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K

Automated Imaging Differentiation for Parkinsonism.

David E Vaillancourt1,2,3,4, Angelos Barmpoutis5, Samuel S Wu6

  • 1Department of Applied Physiology and Kinesiology, University of Florida, Gainesville.

JAMA Neurology
|March 17, 2025
PubMed
Summary
This summary is machine-generated.

Automated Imaging Differentiation for Parkinsonism (AIDP) using MRI and machine learning accurately distinguishes Parkinson disease (PD) from atypical parkinsonian syndromes. This AI-powered tool shows high diagnostic performance, supporting its use in clinical workups.

More Related Videos

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

25.9K
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.4K

Related Experiment Videos

Last Updated: May 22, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.0K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

25.9K
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.4K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence in Medicine
  • Neurology

Background:

  • Differentiating Parkinson disease (PD) from atypical parkinsonian syndromes like multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) is clinically challenging.
  • Magnetic resonance imaging (MRI) combined with machine learning (ML) offers a promising avenue for improved diagnostic accuracy.

Purpose of the Study:

  • To evaluate the diagnostic performance of Automated Imaging Differentiation for Parkinsonism (AIDP), an ML-based approach using 3-T diffusion MRI.
  • To assess AIDP's ability to discriminate between PD, MSA, and PSP.

Main Methods:

  • A prospective, multicenter cohort study involved 249 patients with confirmed PD, MSA, or PSP.
  • Patients were categorized into training and independent testing sets.
  • Support vector machine (SVM) learning was applied to 3-T diffusion MRI data.

Main Results:

  • AIDP demonstrated high accuracy in differentiating PD from atypical parkinsonism (AUROC, 0.96).
  • The model effectively distinguished between MSA and PSP (AUROC, 0.98), PD and MSA (AUROC, 0.98), and PD and PSP (AUROC, 0.98).
  • AIDP predictions showed strong agreement with postmortem neuropathology (93.9% accuracy).

Conclusions:

  • The prospective multicenter study met its primary endpoints, validating AIDP's performance.
  • AIDP shows significant potential for integration into the diagnostic workup of common parkinsonian syndromes.